Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder

European Urology

Volumn 62, Issue 4, 2012, Pages 662-670

  Mayr, Roman ^a   May, Mattias ^b   Martini, Thomas ^a   Lodde, Michele ^a   Comploj, Evi ^a   Pycha, Armin ^a   Strobel, Jenny ^c   Denzinger, Stefan ^d   Otto, Wolfgang ^d   Wieland, Wolfgang ^d   Burger, Maximilian ^d   Fritsche, Hans Martin ^d  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b Urologische Klinik   (Germany)

^c Caritas St Josef Medical Centre   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ACCI; ACE27; ASA; Bladder cancer; Cancer independent mortality; CCI; Comorbidity; Cystectomy; ECOG; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER UROTHELIAL CARCINOMA; CANCER INDEPENDENT MORTALITY; CANCER MORTALITY; CANCER SPECIFIC MORTALITY; CANCER SURVIVAL; COMORBIDITY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA; CAUSE OF DEATH; COMORBIDITY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84865678674     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.03.057     Document Type: Article

References (31)

1. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
2. H.W. Herr, Z. Dotan, S.M. Donat, and D.F. Bajorin Defining optimal therapy for muscle invasive bladder cancer J Urol 177 2007 437 443
3. A. Stenzl, N.C. Cowan, and M. De Santis Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
4. S. Madersbacher, W. Hochreiter, and F. Burkhard Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690 696
5. C.A. Goossens-Laan, O. Visser, and M.C. Hulshof Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume BJU Int 110 2012 226 232
6. Y. Lotan, A. Gupta, and S.F. Shariat Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy J Clin Oncol 23 2005 6533 6539
7. M. May, E. Herrmann, and C. Bolenz Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy Eur Urol 59 2011 712 718
8. A.S. Fairey, N.E. Jacobsen, and M.P. Chetner Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database J Urol 182 2009 85 92 discussion 93
9. T.M. Koppie, A.M. Serio, and A.J. Vickers Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer Cancer 112 2008 2384 2392
10. H. Herr, C. Lee, S. Chang, and S. Lerner Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report J Urol 171 2004 1823 1828 discussion 1827-8
11. L.H.G. Sobin, M.K. Gospodarowicz, and C. Wittekind International Union against Cancer. TNM classification of malignant tumours ed. 7. 2010 Wiley-Blackwell Hoboken, NJ
12. J.F. Piccirillo, R.M. Tierney, I. Costas, L. Grove, and E.L. Spitznagel Jr. Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2004 2441 2447
13. M. Saklad Grading of patients for surgical procedures Anesthesiology 2 1941 281 284
14. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
15. M.M. Oken, R.H. Creech, D.C. Tormey Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
16. R.B. Hines, C. Chatla, and H.L. Bumpers Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer J Clin Oncol 27 2009 4339 4345
17. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
18. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
19. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
20. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
21. Mayr R, May M, Martini T, et al. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int. In press. http://dx.doi.org/10. 1111/j.1464-410X.2012.10938.x.
22. A. Fairey, M. Chetner, and J. Metcalfe Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database J Urol 180 2008 128 134 discussion 134
23. I.I. Megwalu, A. Vlahiotis, M. Radwan, J.F. Piccirillo, and A.S. Kibel Prognostic impact of comorbidity in patients with bladder cancer Eur Urol 53 2008 581 589
24. D.C. Miller, D.A. Taub, R.L. Dunn, J.E. Montie, and J.T. Wei The impact of co-morbid disease on cancer control and survival following radical cystectomy J Urol 169 2003 105 109
25. Novotny V, Zastrow S, Koch R, Wirth MP. Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality. World J Urol. In press.
26. P.J. Bostrom, J. Kossi, M. Laato, and M. Nurmi Risk factors for mortality and morbidity related to radical cystectomy BJU Int 103 2009 191 196
27. B. Malavaud, C. Vaessen, M. Mouzin, P. Rischmann, J.P. Sarramon, and C. Schulman Complications for radical cystectomy: impact of the American Society of Anesthesiologists score Eur Urol 39 2001 79 84
28. X. Gamé, M. Soulié, and P. Seguin Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality Eur Urol 39 2001 525 529
29. G. Lughezzani, M. Sun, and S.F. Shariat A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer Cancer 117 2011 103 109
30. J.R. Gregg, M.S. Cookson, and S. Phillips Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer J Urol 185 2011 90 96
31. C. De Nunzio, A. Cicione, and F. Leonardo Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians Int Urol Nephrol 43 2011 663 667